Peadar Tóibín
Question:661. Deputy Peadar Tóibín asked the Minister for Health the number of lung cancer diagnoses in Ireland in each of the past ten years and to date in 2022. [60802/22]
View answerTuesday, 6 December 2022
Questions (661, 662, 663, 664, 665, 666)
Peadar Tóibín
Question:662. Deputy Peadar Tóibín asked the Minister for Health the number of breast cancer diagnosis in Ireland in each of the past ten years and to date in 2022. [60803/22]
View answerPeadar Tóibín
Question:663. Deputy Peadar Tóibín asked the Minister for Health the number of cervical cancer diagnosis in Ireland in each of the past ten years and to date in 2022. [60804/22]
View answerPeadar Tóibín
Question:664. Deputy Peadar Tóibín asked the Minister for Health the number of ovarian cancer diagnosis in Ireland in each of the past ten years and to date in 2022. [60805/22]
View answerPeadar Tóibín
Question:665. Deputy Peadar Tóibín asked the Minister for Health the number of brain cancer diagnosis in Ireland in each of the past ten years and to date in 2022. [60806/22]
View answerPeadar Tóibín
Question:666. Deputy Peadar Tóibín asked the Minister for Health the number of skin cancer diagnosis in Ireland in each of the past ten years and to date in 2022. [60807/22]
View answerWritten answers
I propose to take Questions Nos. 661 to 666, inclusive, together.
The National Cancer Registry of Ireland (NCRI) has a statutory obligation to collate information in relation to national cancer incidence across all tumour types. This information will typically only be made available 2 to 3 years after the year of incidence, in keeping with international standards.
Successive National Cancer Strategies have delivered continuing improvements in outcomes for Irish cancer patients in terms of earlier diagnosis, better treatment, and improved rates of survival.
NCRI data shows substantial progress being made to control the four major cancers (prostate, breast, lung and colorectal), with mortality rates falling or stabilising for each. These comprise over half of all invasive tumours (not including rarely fatal nonmelanoma skin cancers).
Treatment in our medical oncology, radiation oncology and surgical oncology services also continues to improve, with an estimated 200,000 people in Ireland living with and beyond cancer.
The NCRI published its "2022 Annual Statistical Report: Cancer in Ireland 1994-2020" last week. This report on the status of cancer in Ireland includes updated statistics on cancer incidence, mortality and survival for patients diagnosed in Ireland 1994 – 2020.
Key findings include:
- Over 50% increase in numbers of cancer survivors compared with a decade ago as, for the first time, the number of patients living after an invasive cancer diagnosis has exceeded the 200,000-mark, equivalent to 1 in 24 people in Ireland. This reflects the ongoing improvement in cancer survival.
- More complete data on the impact of the COVID-19 pandemic on cancer diagnoses indicates that the pandemic resulted in a 10% reduction in cancer diagnoses (based on all cancers) or 11% (based on microscopically verified cancers) in 2020, compared to what was expected that year.
- Median age at diagnosis for all cancer combined (excluding non-melanoma skin cancers) was 69 years in men and 67 years in women, with little change over time. The median age at death for all invasive cancers combined was 74 years in both men and women, an increase compared with the median of 72 years in both men and women during 1994-1998, consistent with improved cancer survival.
- Further evidence of improvements in colorectal cancer control in men, as this cancer drops from 2nd to 3rd most common cause of cancer deaths in men.
In answer to the Deputy's queries a table is provided below with numbers of cases diagnosed each year 2011 to 2020, for the cancers listed, based on the analyses recently undertaken for the latest NCRI annual statistical report, which was published on 29th November 2022. Data provided is up to 2020, as analysis is still underway on cases diagnosed in 2021, and data for 2022 is incomplete.
|
Diagnosis year |
ICD-10 C34 |
ICD-10 C43 |
ICD-10 C44 |
ICD-10 C50 |
ICD-10 C53 |
ICD-10 C56 |
ICD-10 C71 |
|
|
Lung cancer |
Melanoma skin cancer |
Non-melanoma skin cancer |
Breast cancer |
Cervical cancer |
Ovarian cancer |
Brain cancer |
|
|
|
|
|
|
|
|
|
|
2011 |
2,276 |
895 |
9,331 |
2,891 |
339 |
355 |
349 |
|
2012 |
2,376 |
875 |
9,470 |
2,919 |
301 |
389 |
350 |
|
2013 |
2,460 |
1,007 |
9,875 |
3,029 |
286 |
359 |
332 |
|
2014 |
2,458 |
1,056 |
10,370 |
2,949 |
282 |
425 |
384 |
|
2015 |
2,560 |
1,137 |
10,747 |
3,149 |
249 |
418 |
359 |
|
2016 |
2,572 |
1,144 |
10,731 |
3,293 |
291 |
387 |
351 |
|
2017 |
2,713 |
1,113 |
11,521 |
3,387 |
296 |
402 |
374 |
|
2018 |
2,700 |
1,127 |
12,017 |
3,629 |
303 |
396 |
422 |
|
2019 |
2,766 |
1,228 |
12,172 |
3,588 |
272 |
385 |
452 |
|
2020 |
2,539 |
1,154 |
10,306 |
2,959 |
185 |
422 |
460 |
|
National Cancer Registry Ireland, based on data extracted 19/10/2022. |
|
Question No. 662 answered with Question No. 661.
Question No. 663 answered with Question No. 661.
Question No. 664 answered with Question No. 661.
Question No. 665 answered with Question No. 661.
Question No. 666 answered with Question No. 661.